All posts tagged
Meet the co-developer of the first commercial mAb and gene therapy
EMA designates uniQure’s gene therapy for hemophilia a priority
Goodbye Glybera! The World’s First Gene Therapy will be Withdrawn
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?
The FDA gives Fast Track Priority to uniQure’s Hemophilia B Gene Therapy
How is Biotech Innovating in Hemophilia? Gene Therapy, Antibodies, RNAi… Let’s Review
UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan
After a Rough Year, uniQure CMO discusses a Comeback
UPDATE: UniQure keeps afloat with a New CEO and More Clinical Data
These are 10 of the Hottest Biotech Hubs in Europe
UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy
Labiotech UG, All Rights Reserved -
Send this to friend